BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18561786)

  • 21. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
    Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
    Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of weekly epoetin Beta in the treatment of chemotherapy-induced anemia in solid tumors].
    Oudard S; Quoix E; Jenabian A; Bergougnoux L; Chouahnia K; Ferrero JM; Misset JL; Spaëth D
    Therapie; 2009; 64(1):17-25. PubMed ID: 19463249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythropoietin in oncology. II. Evaluation of the effectiveness of erythropoietin in hematologic and oncologic diseases].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 May; 42(5):351-8. PubMed ID: 8768296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epoetin for cancer patients: a boon or a danger?
    Brower V
    J Natl Cancer Inst; 2003 Dec; 95(24):1820-1. PubMed ID: 14679148
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical utility of epoetin in cancer patients: a matter of perspective.
    Barosi G; Marchetti M
    Haematologica; 2000 May; 85(5):449-50. PubMed ID: 10800156
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy-associated thrombosis.
    Ashrani AA; Rajkumar SV
    Cancer Treat Res; 2009; 148():181-206. PubMed ID: 19377925
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
    Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
    [No Abstract]   [Full Text] [Related]  

  • 28. PHARMAC and erythropoietin for cancer patients.
    Grocott R; Metcalfe S; Moodie P
    N Z Med J; 2006 Jun; 119(1236):U2039. PubMed ID: 16807581
    [No Abstract]   [Full Text] [Related]  

  • 29. Controversial effect of epoetin in cancer: grounds for a translational research exercise?
    Apolone G
    Eur J Cancer; 2004 Jun; 40(9):1289-91. PubMed ID: 15177486
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
    Mousa SA; Petersen LJ
    Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin to treat anaemia in patients with head and neck cancer.
    Powles T; Shamash J; Liu W
    Lancet; 2004 Jan; 363(9402):82. PubMed ID: 14724015
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron supplement in cancer patients receiving erythropoietin.
    Pedrazzoli P; Tullio C; Cerea G; Siena S
    J Clin Oncol; 2004 Nov; 22(21):4428; author reply 4428-9. PubMed ID: 15514387
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe fatigue in cancer. Causes from A as anemia to Z as cytostatics].
    MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152776
    [No Abstract]   [Full Text] [Related]  

  • 35. Anemia: cancer patients who are very likely to benefit often go untreated.
    J Support Oncol; 2003; 1(1):68. PubMed ID: 15352647
    [No Abstract]   [Full Text] [Related]  

  • 36. Readers disagree with erythropoietin alpha described as nontraditional treatment.
    Buchsel PC; Murphy BJ; Newton S
    Oncol Nurs Forum; 2000; 27(10):1497. PubMed ID: 11103370
    [No Abstract]   [Full Text] [Related]  

  • 37. Anemia management in oncology and hematology.
    Spivak JL; Gascón P; Ludwig H
    Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of erythropoietin in cancer-related anaemia: a double-edged sword?
    Guan X; Chen L
    J Int Med Res; 2008; 36(1):1-8. PubMed ID: 18230261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand.
    Roungrong J; Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S119-25. PubMed ID: 19255987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.